Cargando…

Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences

Communication about palliative treatment options requires a balance between providing patients with sufficient information and not providing unwanted information. Surveys have indicated that many patients with advanced cancer express a wish to receive detailed information. In this prospective multic...

Descripción completa

Detalles Bibliográficos
Autores principales: Oostendorp, Linda J. M., Ottevanger, Petronella B., van de Wouw, Agnes J., Honkoop, Aafke H., Los, Maartje, van der Graaf, Winette T. A., Stalmeier, Peep F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988994/
https://www.ncbi.nlm.nih.gov/pubmed/25985960
http://dx.doi.org/10.1007/s13187-015-0845-9
_version_ 1782448494331559936
author Oostendorp, Linda J. M.
Ottevanger, Petronella B.
van de Wouw, Agnes J.
Honkoop, Aafke H.
Los, Maartje
van der Graaf, Winette T. A.
Stalmeier, Peep F. M.
author_facet Oostendorp, Linda J. M.
Ottevanger, Petronella B.
van de Wouw, Agnes J.
Honkoop, Aafke H.
Los, Maartje
van der Graaf, Winette T. A.
Stalmeier, Peep F. M.
author_sort Oostendorp, Linda J. M.
collection PubMed
description Communication about palliative treatment options requires a balance between providing patients with sufficient information and not providing unwanted information. Surveys have indicated that many patients with advanced cancer express a wish to receive detailed information. In this prospective multicenter study, the information desire of patients with advanced breast or colorectal cancer was further investigated by offering treatment-related information to patients using a decision aid (DA). In addition, this study explored oncologists’ awareness of their patients’ information desire. Seventy-seven patients with advanced breast or colorectal cancer facing the decision whether to start second-line palliative chemotherapy were offered a DA by a nurse. This DA contained information on adverse events, tumor response, and survival. The nurse asked the patient whether each information item was desired. Ninety-five percent of patients chose to receive information on adverse events, 91 % chose to receive information on tumor response, and 74 % chose to receive information on survival. Oncologists’ judgment of patients’ information desire was 100, 97, and 81 %, respectively. For all three information items together, oncologists correctly judged the information desire of 62 % of patients. This study confirms that many patients with advanced cancer wish to receive detailed information on the benefits and risks of palliative treatment options when the information is actually available. Oncologists were adequately aware of this high information desire, but had some difficulty judging the information desire of individual patients. A stepped approach to giving information (“preview, ask, tell, ask”) may help to better meet patients’ information needs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13187-015-0845-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4988994
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-49889942016-09-01 Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences Oostendorp, Linda J. M. Ottevanger, Petronella B. van de Wouw, Agnes J. Honkoop, Aafke H. Los, Maartje van der Graaf, Winette T. A. Stalmeier, Peep F. M. J Cancer Educ Article Communication about palliative treatment options requires a balance between providing patients with sufficient information and not providing unwanted information. Surveys have indicated that many patients with advanced cancer express a wish to receive detailed information. In this prospective multicenter study, the information desire of patients with advanced breast or colorectal cancer was further investigated by offering treatment-related information to patients using a decision aid (DA). In addition, this study explored oncologists’ awareness of their patients’ information desire. Seventy-seven patients with advanced breast or colorectal cancer facing the decision whether to start second-line palliative chemotherapy were offered a DA by a nurse. This DA contained information on adverse events, tumor response, and survival. The nurse asked the patient whether each information item was desired. Ninety-five percent of patients chose to receive information on adverse events, 91 % chose to receive information on tumor response, and 74 % chose to receive information on survival. Oncologists’ judgment of patients’ information desire was 100, 97, and 81 %, respectively. For all three information items together, oncologists correctly judged the information desire of 62 % of patients. This study confirms that many patients with advanced cancer wish to receive detailed information on the benefits and risks of palliative treatment options when the information is actually available. Oncologists were adequately aware of this high information desire, but had some difficulty judging the information desire of individual patients. A stepped approach to giving information (“preview, ask, tell, ask”) may help to better meet patients’ information needs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13187-015-0845-9) contains supplementary material, which is available to authorized users. Springer US 2015-05-20 2016 /pmc/articles/PMC4988994/ /pubmed/25985960 http://dx.doi.org/10.1007/s13187-015-0845-9 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Oostendorp, Linda J. M.
Ottevanger, Petronella B.
van de Wouw, Agnes J.
Honkoop, Aafke H.
Los, Maartje
van der Graaf, Winette T. A.
Stalmeier, Peep F. M.
Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences
title Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences
title_full Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences
title_fullStr Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences
title_full_unstemmed Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences
title_short Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences
title_sort patients’ preferences for information about the benefits and risks of second-line palliative chemotherapy and their oncologist’s awareness of these preferences
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988994/
https://www.ncbi.nlm.nih.gov/pubmed/25985960
http://dx.doi.org/10.1007/s13187-015-0845-9
work_keys_str_mv AT oostendorplindajm patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences
AT ottevangerpetronellab patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences
AT vandewouwagnesj patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences
AT honkoopaafkeh patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences
AT losmaartje patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences
AT vandergraafwinetteta patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences
AT stalmeierpeepfm patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences